Jens D Lundgren, MD
Quick facts
Marketed products
- COMIRNATY - BioNTech Manufacturing GmbH · Immunology / Infectious Disease
COMIRNATY is an mRNA vaccine that instructs cells to produce the SARS-CoV-2 spike protein, triggering an immune response to prevent COVID-19 infection. - COVID-19 Vaccine AstraZeneca suspension for injection
- Johnson & Johnson
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: